Bellevue Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Hold |
3,741
| – | – | ﹤0.01% | 133 |
|
|
2025
Q1 | $150K | Sell |
3,741
-7,200
| -66% | -$289K | ﹤0.01% | 138 |
|
|
2024
Q4 | $515K | Hold |
10,941
| – | – | 0.01% | 126 |
|
|
2024
Q3 | $578K | Sell |
10,941
-5,718
| -34% | -$302K | 0.01% | 125 |
|
|
2024
Q2 | $903K | Buy |
16,659
+1,019
| +7% | +$55.2K | 0.01% | 122 |
|
|
2024
Q1 | $1.1M | Sell |
15,640
-3,260
| -17% | -$229K | 0.02% | 118 |
|
|
2023
Q4 | $1.58M | Sell |
18,900
-18,200
| -49% | -$1.52M | 0.02% | 113 |
|
|
2023
Q3 | $1.09M | Hold |
37,100
| – | – | 0.02% | 126 |
|
|
2023
Q2 | $1.21M | Sell |
37,100
-17,100
| -32% | -$558K | 0.02% | 125 |
|
|
2023
Q1 | $1.91M | Hold |
54,200
| – | – | 0.03% | 117 |
|
|
2022
Q4 | $2.48M | Sell |
54,200
-17,000
| -24% | -$779K | 0.03% | 122 |
|
|
2022
Q3 | $3.45M | Buy |
71,200
+4,800
| +7% | +$233K | 0.05% | 113 |
|
|
2022
Q2 | $2.61M | Sell |
66,400
-2,600
| -4% | -$102K | 0.04% | 122 |
|
|
2022
Q1 | $2.54M | Buy |
+69,000
| New | +$2.54M | 0.03% | 129 |
|